Skip to main content

Moderna posts surprise quarterly profit even as Covid vaccines sales plummet

Moderna reiterated its full-year 2024 sales guidance of roughly $4 billion.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.